Figures & data
Scheme 1. Synthesis of intermediate products and target products of N-alkyl-deoxynojirimycin derivatives. Reagents and condition: (a) K2CO3, acetone, dibromo alkane, 65 °C, overnight or Et3N, acetone, dibromo alkane, 65 °C; (b) K2CO3, DMF, 85 °C, 6 h.
![Scheme 1. Synthesis of intermediate products and target products of N-alkyl-deoxynojirimycin derivatives. Reagents and condition: (a) K2CO3, acetone, dibromo alkane, 65 °C, overnight or Et3N, acetone, dibromo alkane, 65 °C; (b) K2CO3, DMF, 85 °C, 6 h.](/cms/asset/f3377777-bd92-4872-9d6a-088b9da0b483/ienz_a_1826941_sch0001_b.jpg)
Table 1. In vitro α-glucosidase inhibitory activity of compound 25–44.
Figure 2. Kinetic analysis of α-glucosidase inhibition by compounds 43, 40, and 34. (A) The Lineweaver–Burk plots in the absence and presence of different concentrations of compound 43; (B) The Lineweaver–Burk plots in the absence and presence of different concentrations of compound 40; (C) The Lineweaver–Burk plots in the absence and presence of different concentrations of compound 34.
![Figure 2. Kinetic analysis of α-glucosidase inhibition by compounds 43, 40, and 34. (A) The Lineweaver–Burk plots in the absence and presence of different concentrations of compound 43; (B) The Lineweaver–Burk plots in the absence and presence of different concentrations of compound 40; (C) The Lineweaver–Burk plots in the absence and presence of different concentrations of compound 34.](/cms/asset/242ed0df-4870-4db9-bc9d-a7036c3bf2fd/ienz_a_1826941_f0002_c.jpg)
Table 2. The detailed information of molecular docking results of compounds 34, 40, 41, 43, and acarbose.